Polar Capital Funds PLC has increased its shareholding in Nephrocare Health Services Limited through a recent acquisition disclosed under Regulation 29 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition was completed on December 19, 2025, through open market transactions.

Acquisition Details

Polar Capital Funds PLC, through three healthcare funds, acquired an additional 0.214% stake in Nephrocare Health Services, increasing its total holding to 5.057%. The acquisition involved 214,331 shares purchased across three specialized healthcare funds managed by Polar Capital Funds PLC.

Pre and Post-Acquisition Holdings

Before this acquisition, Polar Capital Funds held a combined stake of 4.843% in Nephrocare Health Services totaling 4,859,925 shares. The Healthcare Opportunities Fund dominated the pre-acquisition holdings with 1,846,758 shares representing 4.830% of the company.

Company Share Capital Structure

Nephrocare Health Services maintains a total equity share capital of 100,340,717 shares, which remains unchanged both before and after this acquisition. The company's shares are listed on both BSE and NSE exchanges. Polar Capital Funds PLC does not belong to the promoter or promoter group of Nephrocare Health Services.

Transaction Characteristics

The acquisition was executed entirely through open market purchases on December 19, 2025, with no involvement of preferential allotment, rights issue, or other special arrangements. The disclosure indicates that Polar Capital holds no encumbered shares, warrants, convertible securities, or voting rights other than those arising from equity shareholding in the target company. The regulatory filing was signed by Stephen Amoah from London, UK, on December 22, 2025, confirming compliance with Indian securities regulations.

Nephrocare Health Services Limited has officially informed BSE Limited and National Stock Exchange of India Limited about the appointment of its Compliance Officer under SEBI regulations. The company submitted the notification on December 22, 2025, confirming the appointment details and compliance with regulatory requirements.

Compliance Officer Appointment Details

The company appointed Kishore Kathri as Company Secretary and Compliance Officer effective July 16, 2025. The appointment was made in accordance with Regulation 6(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Professional Background and Qualifications

Kishore Kathri brings substantial expertise to his role at Nephrocare Health Services Limited. He is responsible for ensuring managerial, secretarial, and regulatory compliances of the company. Kathri holds an associate membership with the Institute of Company Secretaries of India and possesses comprehensive educational qualifications.

His academic credentials include a bachelor's degree in commerce and law, along with a master's degree in corporate and securities laws, all obtained from Osmania University, Hyderabad. This educational foundation provides him with the necessary knowledge base for his compliance responsibilities.

Professional Experience

Kathri has accumulated over 12 years of professional experience across various domains critical to his current role. His expertise spans:

• Corporate governance
• Regulatory compliance
• Board administration
• Contract drafting
• Legal advisory services

His experience encompasses work with listed companies in both manufacturing and services sectors. Prior to joining Nephrocare Health Services Limited, Kathri was associated with several notable organizations including Birla Nu Limited (formerly HIL Limited), GOCL Corporation Limited, Vishnu Chemicals Limited, Granules India Limited, and Corpus Software Private Limited.

Regulatory Compliance

The appointment notification was submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III to the said Regulations. This ensures full compliance with regulatory requirements for changes in Key Managerial Personnel.

The company continues to maintain its compliance obligations following its listing on stock exchanges, with Kathri serving as the designated Compliance Officer to oversee adherence to all applicable regulations and requirements.